Ind-Swift Laboratories Ltd

📋 IndSwift Laboratories Approves Preferential Issue of Up to 70,00,000 Warrants to Promoter Group

- Preferential issue of up to 70,00,000 Fully Convertible Warrants approved for Essix Biosciences Limited (Promoter & Promoter Group)

- Issue price set at ₹196 per Warrant, aggregating up to ₹1,37,20,00,000

- Each Warrant convertible into one Equity Share of face value ₹10 within 18 months from allotment

- Extraordinary General Meeting scheduled for August 05, 2026

- Board approved alteration in Article of Association (Article 76) subject to shareholder approval